AbbVie (ABBV) Non-Current Assets (2012 - 2026)

AbbVie (ABBV) has 15 years of Non-Current Assets data on file, last reported at $102.9 billion in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $102.9 billion, down 5.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $421.1 billion (down 4.69% YoY), and the FY2025 annual result was $104.9 billion, down 4.27% from the prior year.
• Non-Current Assets declined to $102.9 billion in Q1 2026 per ABBV's latest filing, from $104.9 billion in the prior quarter.
• Over five years, Non-Current Assets peaked at $116.7 billion in Q1 2022 and troughed at $101.7 billion in Q4 2023.
• A 5-year average of $108.5 billion and a median of $108.1 billion in 2024 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets grew 12.27% in 2024, then decreased 8.89% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $110.3 billion in 2022, then declined by 7.82% to $101.7 billion in 2023, then advanced by 7.74% to $109.6 billion in 2024, then decreased by 4.27% to $104.9 billion in 2025, then dropped by 1.87% to $102.9 billion in 2026.
• Business Quant data shows ABBV's Non-Current Assets at $102.9 billion in Q1 2026, $104.9 billion in Q4 2025, and $105.4 billion in Q3 2025.